Mary Beth Scholand,
MD
Languages Spoken: English
Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.
Clinical Locations
801-213-3200
801-213-4500
801-581-2000
Pulmonary, Clinic 3
801-581-7806
Fax: (801) 585-3555
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor |
| Academic Divisions | Pulmonary |
| Board Certification | American Board of Internal Medicine (Sub: Pulmonary Disease) National Board of Medical Examiners |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.7/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 19, 2022
SUGAR HOUSE HEALTH CENTER
Dr Scholand is a good listener
UofU Patient
March 14, 2022
UH HOSPITALS AND CLINICS
Good visit overall
UofU Patient
March 06, 2022
SUGAR HOUSE HEALTH CENTER
Gave me answers for future plan of care.
UofU Patient
March 01, 2022
UH HOSPITALS AND CLINICS
Dr. Scholand showed empathy for my problem, understood my concerns about further medications. She was reassuring and assured me of her cooperation with my other doctors in Canada. I am thankful to her. She referred me to the cough clinic for further diagnoses. I am waiting for the appointment.
UofU Patient
February 27, 2022
SUGAR HOUSE HEALTH CENTER
Dr. Scholand is very professional and caring! She spends time with the patient and is very conscious of connecting all the other patients doctors into the circle.
UofU Patient
February 19, 2022
UH HOSPITALS AND CLINICS
I love, love, love Drs Frech and Sholand!! Had this disease for over 20 yrs. They've taught me more in the last 2 years than any doc at the UDUB
UofU Patient
February 08, 2022
SOUTH JORDAN HEALTH CENTER
Dr. Scholand is always so attentive to my needs while being very friendly.
UofU Patient
February 07, 2022
FARMINGTON HEALTH CENTER
I would recommend Dr. Scholand in a heart beat
UofU Patient
February 06, 2022
SUGAR HOUSE HEALTH CENTER
Mary Beth Scholand is an excellent health care professional, but what is most amazing and for which I am most grateful is the human touch. The sensitivity and her genuine interest in my well being as a patient. Extremely communicative and very clear. She answers all my questions and gives me options. It is a real privilege to be treated by her.
UofU Patient
January 24, 2022
UH HOSPITALS AND CLINICS
Drs that I've talked with after my right lung collapsed on the 30th of Dec, 2021, have all spoken highly of her and her work ethic once I told them she was my pulmonary doctor.
UofU Patient
January 18, 2022
SOUTH JORDAN HEALTH CENTER
Dr. Scholand is a kind caring doctor, who listens to you and explains everything
UofU Patient
January 15, 2022
SUGAR HOUSE HEALTH CENTER
Care I receive is excellent. It is individualized to me.
UofU Patient
January 08, 2022
UH HOSPITALS AND CLINICS
Excellant communication between myself and the doctor
UofU Patient
January 07, 2022
SUGAR HOUSE HEALTH CENTER
Dr gave me all the ins and outs
UofU Patient
December 28, 2021
SUGAR HOUSE HEALTH CENTER
Dr. Scholand is one of the most caring people I know. She makes me feel that she cares about me personally, not just as a patient. I am so grateful for her.
UofU Patient
December 18, 2021
SUGAR HOUSE HEALTH CENTER
Excellent visit with Dr. Scholand. Clear and informative regarding my issues
UofU Patient
December 16, 2021
SOUTH JORDAN HEALTH CENTER
Doctor Mary Beth Scholand is the best. She is very knowledgeable, concerned answers all my questions and does not rush through the exam.
UofU Patient
December 12, 2021
FARMINGTON HEALTH CENTER
Very thorough. Gave me choices to consider. Validated my actions and concerns. Great care from dr Scholand
UofU Patient
December 12, 2021
FARMINGTON HEALTH CENTER
Pleasure to work with her
UofU Patient
December 03, 2021
SUGAR HOUSE HEALTH CENTER
Dr. Scholand was wonderful in that she was thorough in asking the right questions and explaining the coming options.
UofU Patient
December 02, 2021
SOUTH JORDAN HEALTH CENTER
Dr Scholand is the very best I have seen and that says a lot
UofU Patient
November 21, 2021
FARMINGTON HEALTH CENTER
Good
UofU Patient
November 19, 2021
FARMINGTON HEALTH CENTER
Caregiver gave little explanation of progress or lack of.
UofU Patient
October 21, 2021
SUGAR HOUSE HEALTH CENTER
Good
UofU Patient
October 08, 2021
SUGAR HOUSE HEALTH CENTER
Dr Scholand is interested in my well being.
UofU Patient
September 23, 2021
UH HOSPITALS AND CLINICS
Good
UofU Patient
September 18, 2021
UH HOSPITALS AND CLINICS
Dr. SCHOLAND IS EXCEPTIONAL in watching out for me.
UofU Patient
September 12, 2021
UH HOSPITALS AND CLINICS
Dr Scholand is amazing, she listens and explains her feelings honestly. I so appreciate her.
UofU Patient
September 11, 2021
UH HOSPITALS AND CLINICS
Excellent care!
UofU Patient
August 30, 2021
SOUTH JORDAN HEALTH CENTER
Dr Scholand is a wonderful doctor kind, caring, works hard to find help for your illness,
UofU Patient
August 26, 2021
SOUTH JORDAN HEALTH CENTER
Everyone was very concerned about my medical problems and helped me to make decisions as to what to do.
UofU Patient
August 24, 2021
SUGAR HOUSE HEALTH CENTER
Dr. Scholand is one of the most caring doctors I have ever met. She goes the extra mile to keep me updated on my condition. I feel like she cares about me personally.
UofU Patient
August 22, 2021
FARMINGTON HEALTH CENTER
Incredibly knowledgeable,Professional and easy to ask questions regarding medical issue thorough answers. Developed follow-up plan of care and appointment!
UofU Patient
August 19, 2021
SOUTH JORDAN HEALTH CENTER
Very happy
UofU Patient
August 05, 2021
SUGAR HOUSE HEALTH CENTER
My Doctor knows how to get me to obey.
UofU Patient
July 19, 2021
UH HOSPITALS AND CLINICS
Dr. Scholand was excellant.
UofU Patient
July 02, 2021
SUGAR HOUSE HEALTH CENTER
Dr. Scholand is one of the most caring doctors I have ever met. I feel like she cares about me personally not just as a patient.
UofU Patient
June 27, 2021
FARMINGTON HEALTH CENTER
successful visit.
UofU Patient
June 24, 2021
FARMINGTON HEALTH CENTER
rxcellent
UofU Patient
June 20, 2021
UH HOSPITALS AND CLINICS
Dr. Scholand is wonderful. Very pleasant and professional.
UofU Patient
June 16, 2021
FARMINGTON HEALTH CENTER
very pleased with her interest in my condition and clearly wanting to get me tested, to check how serious it is.
UofU Patient
June 16, 2021
UH HOSPITALS AND CLINICS
Dr Scholand is so very good
UofU Patient
June 13, 2021
SUGAR HOUSE HEALTH CENTER
Dr. was very concerned and helpful with my meds and also talking with my other lung specialist that I have
UofU Patient
June 12, 2021
UH HOSPITALS AND CLINICS
problem still trying to be resolved
UofU Patient
June 12, 2021
UH HOSPITALS AND CLINICS
I don't ever have problems with my provider. Mary Beth is terrific!
UofU Patient
June 07, 2021
UH HOSPITALS AND CLINICS
Dr Scholand is awesome and I appreciate her concerns and kind support
UofU Patient
May 29, 2021
SOUTH JORDAN HEALTH CENTER
dr Scholand - is a fantastic and caring doctor
UofU Patient
May 12, 2021
FARMINGTON HEALTH CENTER
everyone is very kind, and accommodating
UofU Patient
May 09, 2021
SOUTH JORDAN HEALTH CENTER
Dr. Scholand is an amazing doctor- I'm blessed to have her as my pulmonary doctor!
UofU Patient
May 03, 2021
UH HOSPITALS AND CLINICS
The Dr and nurses were very accommodating. They did a great job.
Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.
Academic Locations
Research Statement
Dr. Mary Beth Scholand is an Associate Professor in Pulmonary Medicine. Her clinical practice primarily focuses on interstitial lung disease (ILD) and she is the Director of the ILD Clinic. ILD is a disease category that encompasses many pulmonary conditions, including idiopathic pulmonary fibrosis (IPF), autoimmune lung diseases, and sarcoidosis. Dr. Scholand is the principal investigator on numerous clinical trials which aim to find a treatment for pulmonary fibrosis (both idiopathic and autoimmune in etiology), and is a co-investigator in NIH-funded studies on IPF and chronic obstructive pulmonary disease. In addition, Dr. Scholand studies the relationship between genetic and phenotypic variation to identify genes that significantly elevate the risk of developing ILD, and thus to find new therapeutic targets.
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor |
| Academic Divisions | Pulmonary |
| Board Certification | American Board of Internal Medicine (Sub: Pulmonary Disease) National Board of Medical Examiners |
Research Interests
- Pulmonary Fibrosis
Education History
| Fellowship | University of Utah School of Medicine Pulmonary Medicine Fellow, 2002 |
| Residency | Barnes Hospital Internal Medicine Resident, 1993 |
| Internship | Barnes Hospital Internal Medicine Intern, 1991 |
| Professional Medical | Washington University Medicine M.D., 1990 |
| Undergraduate | Northwestern University B.S., 1986 |
Selected Publications - Journal Articles
Journal Article
- Saketkoo LA LA, Jensen K, Nikoletou D, Newton JJ, Rivera FJ, Howie M, Reese RK, Goodman M, Hart PB, Bembry W, Russell A, Lian I, Lammi MR, Scholand Mb MB, Russell Am AM (2022). Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic. J Patient Exp, 9, 23743735221075556.
- Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, Patel NM, Pulmonary Fibrosis Foundation (2022). Cough-specific Quality of Life Predicts Disease Progression Among Patients with Interstitial Lung Disease: Data from the Pulmonary Fibrosis Foundation Patient Registry. Chest.
- Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA (2022). The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respir Med, 196, 106801.
- Rahaghi FF, Kolaitis NA, Adegunsoye A, de Andrade J, Flaherty KR, Lancaster L, Lee JS, Levine D, Preston IR, Safdar Z, Saggar R, Sahay S, Scholand MB, Shlobin O, Zisman DA, Nathan SD (2022). Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest.
- Huitema MP, Post MC, Grutters JC, Wells AU, Kouranos V, Shlobin OA, Nathan SD, Culver DA, Barney J, Gupta R, Carmona E, Alhamad EH, Scholand MB, Wijsenbeek M, Ganesh S, Lower EE, Engel PJ, Baughman RP (2022). Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study. Sarcoidosis Vasc Diffuse Lung Dis, 38(4), e2021032.
- Lasky JA, Case A, Unterman A, Kreuter M, Scholand MB, Chaudhary S, Lofaro LR, Johnson M, Huang J, Bhorade SM, Kennedy GC (2021). The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc.
- Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varj C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo LA (2021). Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol, 35, 101695.
- Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M (2021). Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel), 11(6).
- Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative (2021). Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA, 325(18), 1841-1851.
- Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris JJ (2021). Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J, 57(2).
- Richeldi L, Scholand MB, Lynch DA, Colby TV, Myers JL, Groshong SD, Chung JH, Benzaquen S, Nathan SD, Davis JR, Schmidt SL, Hagmeyer L, Sonetti D, Hetzel J, Criner GJ, Case AH, Ramaswamy M, Calero K, Gauhar UA, Patel NM, Lancaster L, Choi Y, Pankratz DG, Walsh PS, Lofaro LR, Huang J, Bhorade SM, Kennedy GC, Martinez FJ, Raghu G (2020). Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med, 203(2), 211-220.
- Swigris JJ, Andrae DA, Churney T, Johnson N, Scholand MB, White ES, Matsui A, Raimundo K, Evans CJ (2020). Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. Am J Respir Crit Care Med, 202(12), 1689-1697.
- Rahaghi FF, Safdar Z, Brown AW, de Andrade JA, Flaherty KR, Kaner RJ, King CS, Padilla ML, Noth I, Scholand MB, Shifren A, Nathan SD (2020). Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study. BMC Pulm Med, 20(1), 191.
- Baughman RP, Scholand MB, Rahaghi FF (2020). Clinical phenotyping: role in treatment decisions in sarcoidosis. Eur Respir Rev, 29(155).
- Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Ennis James W 4th, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Mller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand MB (2020). Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev, 29(155).
- Rahaghi FF, Sweiss NJ, Saketkoo LA, Scholand MB, Barney JB, Gerke AK, Lower EE, Mirsaeidi M, OHare L, Rumbak MJ, Samavati L, Baughman RP (2020). Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. Eur Respir Rev, 29(155).
- Saketkoo LA, Scholand MB, Lammi MR, Russell AM (2020). Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials. J Scleroderma Relat Disord, 5(2 Suppl), 48-60.
- Richeldi L, Fernndez Prez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G (2019). Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Respir Med, 8(1), 25-33.
- Patel NM, Kulkarni T, Dilling D, Scholand MB, Interstitial and Diffuse Lung Disease Network Steering Committee (2019). Preoperative Evaluation of Patients With Interstitial Lung Disease. Chest, 156(5), 826-833.
- Wuyts W, Antin-Ozerkis D, Huggins JT, LaCamera PP, Spagnolo P, Vakov M, Wijsenbeek MS, Polman B, Kirchgaessler KU, Scholand MB (2019). Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials. Respir Med, 150, 120-125.